To evaluate trends in transcatheter hemodialysis conduit procedures in the Medicare population over a recent 15-year interval. Aggregate national claims data were extracted from CMS PSPS Master Files from 2001-2015 for hemodialysis conduit angiography and thrombectomy procedures. Utilization was stratified by billing specialty and site of service. Additionally, individual claims data from 2004-2015 CMS 5% Research Identifiable Files were used to assess state-level utilization. Utilization was normalized per 100,000 Medicare fee-for-service beneficiaries. From 2001-2015, hemodialysis conduit angiography utilization rates increased from 385 to 1,045 per 100,000 beneficiaries [compound annual growth rate (CAGR) +7.4%)], and thrombectomy rates increased from 114 to 168 (CAGR +2.8%). The CAGR for angiography was, by specialty, +1.5% for radiologists, +18.4% for surgeons, and +24.0% for nephrologists, and by site, +29.1% for office and +0.8% for hospital settings. Radiologists’ overall market share of angiography decreased from 81.5% in 37.0%. By combination of specialty and site of service, angiography utilization growth was greatest for nephrologists in the office (from 5 to 265) and surgeons in the office (0 to 128). The greatest decline was for radiologists in the hospital (299 to 205). At the state level, there was marked heterogeneity in dialysis angiography utilization in 2015 [0 (Wyoming) to 1,1,73 (Georgia)], temporal change in angiography utilization from 2004-2015 [CAGR -100.0% (Wyoming) to +19.9% (Nevada)], and radiologists’ 2015 market share [4.8% (Washington DC) to 100.0% (North Dakota)]. Nonetheless, radiologists’ market share decreased in 49 states, and in some states dramatically (e.g., in Nevada, from 100.0% in 2004 to 6.7% in 2015). Transcatheter dialysis conduit angiography utilization has grown substantially, and more so than thrombectomy. This growth has been accompanied by a drastic market shift from radiologists in the hospital to nephrologists and surgeons in the office. Despite wide geographic heterogeneity across the U.S., decreasing radiologist market share has been observed in nearly every state.